Coronavirus Disease (COVID-19) Situation Reports|WHO

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Situation in numbers (by WHO Region)
Total (new cases in last 24 hours)
Globally 12 768 307 cases (215 539) 566 654 deaths (5 037) Africa 477 575 cases (16 279) 8 253 deaths (161) Americas 6 669 879 cases (129 657) 286 577 deaths (3 220) Eastern Mediterranean 1 286 651 cases (15 313) 31 228 deaths (576) Europe 2 925 686 cases (18 029) 203 584 deaths (229) South-East Asia 1 163 556 cases (33 309) 29 258 deaths (618) Western Pacific 244 219 cases (2 952) 7 741 deaths (163)

Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths, by WHO region. Data as of 10 AM CEST, 13 July 2020**

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case

Africa

South Africa 276 242 12 058 4 079 108 Community transmission 0

Nigeria 32 558 571 740 16 Community transmission 0

Ghana 24 518 270 139 4 Community transmission 0

Algeria 19 195 483 1 011 7 Community transmission 0 Cameroon 15 173 257 359 0 Community transmission 0 Côte d’Ivoire 12 766 714 84 3 Community transmission 0 Kenya 10 105 379 185 1 Community transmission 0 Senegal 8 135 121 148 3 Community transmission 0 Democratic Republic of the Congo 8 032 62 188 0 Community transmission 0 Ethiopia 7 766 206 128 1 Community transmission 0 Guinea 6 141 97 37 0 Community transmission 0 Gabon 5 942 0 46 0 Community transmission 2 Mauritania 5 275 149 147 3 Clusters of cases 0 Madagascar 4 867 289 35 1 Clusters of cases 0 Central African Republic 4 288 0 53 0 Community transmission 1 Mali 2 411 5 121 0 Community transmission 0 Malawi 2 364 103 38 5 Clusters of cases 0 South Sudan 2 148 9 41 0 Clusters of cases 0 Congo 2 103 0 47 0 Community transmission 1 Zambia 1 895 0 42 0 Community transmission 5 Guinea-Bissau 1 842 0 25 0 Community transmission 2

Cabo Verde 1 698 75 19 0 Clusters of cases 0 Sierra Leone 1 635 17 63 0 Community transmission 0 Benin 1 378 0 26 0 Community transmission 1 Eswatini 1 351 40 20 2 Clusters of cases 0 Rwanda 1 337 38 4 1 Sporadic cases 0 Mozambique 1 157 22 9 0 Clusters of cases 0 Niger 1 099 0 68 0 Community transmission 2 Equatorial Guinea 1 043 0 12 0 Community transmission 50 Burkina Faso 1 033 13 53 – 1 Community transmission 0 Uganda 1 025 12 0 0 Sporadic cases 0 Liberia 1 010 12 51 4 Community transmission 0 Zimbabwe 985 3 18 0 Sporadic cases 0 Chad 880 6 75 1 Community transmission 0 Namibia 785 72 1 0 Sporadic cases 0 Togo 720 10 15 0 Community transmission 0 United Republic of Tanzania 509 0 21 0 Community transmission 66 Angola 506 23 26 1 Clusters of cases 0 São Tomé and Príncipe 409 2 12 0 Clusters of cases 0 Botswana 399 85 1 0 Clusters of cases 0 Mauritius 342 0 10 0 Clusters of cases 6 Comoros 317 3 7 0 Community transmission 0 Burundi 258 8 1 0 Clusters of cases 0 Lesotho 233 49 2 1 Sporadic cases 0

Eritrea 232 0 0 0 Sporadic cases 3 Seychelles 100 0 0 0 Clusters of cases 3 Gambia 64 0 3 0 Sporadic cases 3 Territoriesii
Mayotte 2 711 0 40 0 Clusters of cases 2 Réunion 593 16 3 0 Clusters of cases 0

Americas

United States of America 3 225 950 62 369 134 392 906 Community transmission 0

Brazil 1 839 850 39 023 71 469 1 071 Community transmission 0

Peru 322 710 3 064 11 682 182 Community transmission 0

Chile 315 041 3 012 6 979 98 Community transmission 0 Mexico 295 268 6 094 34 730 539 Community transmission 0 Colombia 145 362 4 586 5 119 194 Community transmission 0 Canada 107 347 221 8 773 14 Community transmission 0 Argentina 97 509 3 449 1 818 31 Community transmission 0 Ecuador 67 870 661 5 047 16 Community transmission 0 Bolivia (Plurinational State of) 47 200 1 635 1 754 52 Community transmission 0 Dominican Republic 44 532 1 418 897 17 Community transmission 0 Panama 44 332 1 075 893 30 Community transmission 0 Guatemala 28 598 979 1 172 33 Community transmission 0 Honduras 27 583 530 771 21 Community transmission 0 El Salvador 9 674 283 260 6 Community transmission 0 Venezuela (Bolivarian Republic of) 9 178 375 85 2 Community transmission 0 Costa Rica 7 231 386 28 1 Community transmission 0

Haiti 6 690 73 139 4 Community transmission 0 Paraguay 2 820 84 21 1 Community transmission 0 Cuba 2 426 6 87 0 Clusters of cases 0 Nicaragua 2 411 0 91 0 Community transmission 4 Uruguay 986 1 30 1 Clusters of cases 0 Jamaica 758 5 10 0 Clusters of cases 0 Suriname 741 12 18 0 Clusters of cases 0 Guyana 291 1 17 1 Clusters of cases 0 Trinidad and Tobago 133 0 8 0 Sporadic cases 6 Bahamas 111 3 11 0 Clusters of cases 0 Barbados 103 5 7 0 Clusters of cases 0 Antigua and Barbuda 74 0 3 0 Clusters of cases 1 Belize 37 0 2 0 Sporadic cases 1 Saint Vincent and the Grenadines 29 0 0 0 Sporadic cases 25 Grenada 23 0 0 0 Clusters of cases 47 Saint Lucia 22 0 0 0 Sporadic cases 9 Dominica 18 0 0 0 Clusters of cases 30 Saint Kitts and Nevis 17 0 0 0 No cases 2 Territoriesii
Puerto Rico 9 654 288 167 0 Community transmission 0 French Guiana 5 949 0 26 0 Community transmission 1 Martinique 255 0 15 0 Clusters of cases 1 Cayman Islands 201 0 1 0 Clusters of cases 10 Guadeloupe 190 0 14 0 Clusters of cases 2

United States Virgin Islands 181 14 6 0 Clusters of cases 0 Bermuda 150 0 9 0 Sporadic cases 1 Aruba 105 0 3 0 Sporadic cases 6 Sint Maarten 78 0 15 0 No cases 9 Turks and Caicos Islands 71 5 2 0 Clusters of cases 0 Saint Martin 44 0 3 0 Sporadic cases 8 Curaçao 25 0 1 0 Sporadic cases 12 Falkland Islands (Malvinas) 13 0 0 0 No cases 78 Montserrat 12 0 1 0 No cases 2 British Virgin Islands 8 0 1 0 No cases 58 Bonaire, Sint Eustatius and Saba 7 0 0 0 No cases 48 Saint Barthélemy 6 0 0 0 No cases 104 Anguilla 3 0 0 0 No cases 100 Saint Pierre and Miquelon 2 0 0 0 No cases 3

Eastern Mediterranean

Iran (Islamic Republic of) 257 303 2 186 12 829 194 Community transmission 0

Pakistan 251 625 2 753 5 266 69 Clusters of cases 0

Saudi Arabia 232 259 2 779 2 223 42 Clusters of cases 0

Qatar 103 598 470 147 1 Community transmission 0 Egypt 82 070 912 3 858 89 Clusters of cases 0 Iraq 77 506 2 312 3 150 95 Community transmission 0 Oman 56 015 1 318 257 9 Community transmission 0 Kuwait 54 894 836 390 4 Clusters of cases 0 United Arab Emirates 54 854 401 333 2 Community transmission 0

Afghanistan 34 451 0 1 010 0 Clusters of cases 1 Bahrain 32 941 471 108 4 Clusters of cases 0 Morocco 15 745 203 250 5 Clusters of cases 0 Sudan 10 250 0 650 0 Community transmission 1 Djibouti 4 972 4 56 0 Clusters of cases 0 Somalia 3 059 8 93 1 Sporadic cases 0 Lebanon 2 334 166 36 0 Clusters of cases 0 Yemen 1 469 80 418 53 Community transmission 0 Libya 1 433 44 39 1 Clusters of cases 0 Tunisia 1 263 18 50 0 Sporadic cases 0 Jordan 1 179 3 10 0 Clusters of cases 0 Syrian Arab Republic 394 0 16 0 Community transmission 2

Territoriesii occupied Palestinian territory
7 037 349 39 7 Clusters of cases 0

Europe

Russian Federation 733 699 6 537 11 439 104 Clusters of cases 0 The United Kingdom 289 607 650 44 819 21 Community transmission 0 Spain 253 908 0 28 403 0 Clusters of cases 2 Italy 243 061 234 34 954 9 Community transmission 0 Turkey 212 993 1 012 5 363 19 Community transmission 0 Germany 198 963 159 9 064 1 Clusters of cases 0 France 161 275 0 29 907 0 Clusters of cases 2 Sweden 74 898 0 5 526 0 Community transmission 2 Belarus 64 932 168 464 5 Community transmission 0

Belgium 62 707 101 9 782 0 Community transmission 0 Kazakhstan 59 899 1 646 375 23 Clusters of cases 0 Ukraine 54 133 612 1 398 15 Community transmission 0 Netherlands 50 967 101 6 128 0 Community transmission 0 Portugal 46 512 291 1 660 6 Community transmission 0 Israel 38 015 1 194 357 4 Pending 0 Poland 37 891 370 1 571 3 Community transmission 0 Switzerland 32 713 0 1 685 0 Community transmission 1 Romania 32 535 456 1 884 13 Community transmission 0 Armenia 32 151 182 573 8 Community transmission 0 Ireland 25 628 17 1 746 0 Clusters of cases 0 Azerbaijan 24 041 520 306 8 Clusters of cases 0 Republic of Moldova 19 382 174 642 2 Community transmission 0 Austria 18 847 52 708 2 Community transmission 0 Serbia 18 360 287 393 11 Community transmission 0 Uzbekistan 13 193 487 61 3 Clusters of cases 0 Czechia 13 174 59 352 0 Clusters of cases 0 Denmark 12 946 0 609 0 Community transmission 2 Kyrgyzstan 11 117 488 147 15 Clusters of cases 0 Norway 8 965 0 252 0 Clusters of cases 2 North Macedonia 8 111 144 382 7 Clusters of cases 0 Bulgaria 7 525 853 268 6 Clusters of cases 0 Finland 7 294 15 329 0 Clusters of cases 0 Bosnia and Herzegovina 6 884 482 220 5 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Tajikistan 6 551 46 55 0 Pending 0 Luxembourg 4 925 83 111 1 Community transmission 0 Hungary 4 234 5 595 0 Community transmission 0 Greece 3 803 31 193 0 Clusters of cases 0 Croatia 3 722 50 119 1 Clusters of cases 0 Albania 3 571 200 95 6 Clusters of cases 0 Estonia 2 014 0 69 0 Clusters of cases 1 Slovakia 1 901 8 28 0 Clusters of cases 0 Iceland 1 896 8 10 0 Community transmission 0 Lithuania 1 869 4 79 0 Community transmission 0 Slovenia 1 841 14 111 0 Clusters of cases 0 Montenegro 1 221 57 23 0 Clusters of cases 0 Latvia 1 173 0 30 0 Sporadic cases 1 Cyprus 1 021 7 19 0 Clusters of cases 0 Georgia 995 9 15 0 Sporadic cases 0 Andorra 855 0 52 0 Community transmission 24 San Marino 716 0 42 0 Community transmission 3 Malta 674 0 9 0 Sporadic cases 3 Monaco 99 0 1 0 Sporadic cases 36 Liechtenstein 85 0 1 0 Sporadic cases 6 Holy See 12 0 0 0 Sporadic cases 67 Territoriesii Kosovo[1]
4 888 216 92 1 Community transmission 0

Isle of Man 336 0 24 0 No cases 52 Jersey 325 0 31 0 Community transmission 5 Guernsey 252 0 13 0 Community transmission 71 Faroe Islands 188 0 0 0 Pending 5 Gibraltar 180 0 0 0 Clusters of cases 2 Greenland 13 0 0 0 No cases 45

South-East Asia

India 878 254 28 701 23 174 500 Clusters of cases 0

Bangladesh 183 795 2 666 2 352 47 Community transmission 0

Indonesia 75 699 1 681 3 606 71 Community transmission 0

Nepal 16 801 82 38 0 Clusters of cases 0 Thailand 3 220 3 58 0 Clusters of cases 0 Maldives 2 731 67 13 0 Clusters of cases 0 Sri Lanka 2 617 106 11 0 Clusters of cases 0 Myanmar 331 1 6 0 Clusters of cases 0 Bhutan 84 2 0 0 Sporadic cases 0 Timor-Leste 24 0 0 0 No cases 80

Western Pacific

China 85 568 46 4 648 0 Clusters of cases 0

Philippines 56 259 2 037 1 534 162 Community transmission 0

Singapore 45 961 178 26 0 Clusters of cases 0

Japan 21 868 366 982 0 Clusters of cases 0 Republic of Korea 13 479 62 289 0 Clusters of cases 0

Australia 9 797 244 108 1 Clusters of cases 0 Malaysia 8 718 14 122 0 Clusters of cases 0 New Zealand 1 194 0 22 0 Clusters of cases 1

Viet Nam 372 2 0 0 Clusters of cases 0 Mongolia 230 3 0 0 Sporadic cases 0 Cambodia 156 0 0 0 Sporadic cases 1 Brunei Darussalam 141 0 3 0 No cases 66 Fiji 26 0 0 0 Sporadic cases 1 Lao People’s Democratic Republic 19 0 0 0 Sporadic cases 91 Papua New Guinea 11 0 0 0 Sporadic cases 17 Territoriesii
Guam 304 0 5 0 Clusters of cases 1 French Polynesia 62 0 0 0 Sporadic cases 15
Northern Mariana Islands (Commonwealth of the)
33 0 2 0 Pending 1
New Caledonia 21 0 0 0 Sporadic cases 33

Subtotal for all regions 12 767 566 215 539 566 641 5 037

Other* 741 0 13 0 Not applicable –

Grand total 12768307 215539 566654 5037

**See Annex 1 for data, table and figure notes.

France implementing number of projects in Ukraine – ambassador | Ukraine Today .org

https://ukrainetoday.org/2020/07/13/france-implementing-number-of-projects-in-ukraine-ambassador/

…“If we count the projects that have already been signed, are being implemented and have been funded, in particular, the project to supply helicopters to the Interior Ministry, as well as a new project due to be signed next week to supply patrol boats to the Ukrainian Interior Ministry, a water supply project and other projects for the future, their total budget will reach 1.5 billion euros, which is a very serious amount, ” he said during an online press conference dedicated to the start of a project for the supply of drinking water in Mariupol.

The diplomat said France was considering a number of projects for implementation in Ukraine. The main ones are cooperation in the field of railway transport, which may include both the supply of locomotives and the modernization of railways and railway signaling in Ukraine, he said. In addition, the French side, together with Ukrainian Health Minister Maksym Stepanov, is working on a project to set up a network to prevent and detect early-stage breast cancer, and its budget may reach EUR 24 million, he added.

Alan Tudge says Hong Kong residents fearful of China are not guaranteed Australian visas – ABC News

https://mobile.abc.net.au/news/2020-07-12/hong-kong-visa-acting-minister-for-immigration-alan-tudge/12446754

The package Mr Morrison eventually delivered did not
offer the general visa entitlement for Hongkongers to move to Australia
to live or create a special category for safe haven settlement like the
one offered to persecuted minorities in the Syrian civil war.

However,
Mr Tudge could not guarantee those fearful of returning to Hong Kong
when their visas expired would not be automatically accepted.

“What
we are saying is that people will have the opportunity to apply for
permanent residency, but I mean, if there’s a serious security issue in
relation to that person, they’ll be sent back,” Mr Tudge told Insiders.

“If there’s a character concern, they’ll be sent back.”

Nation of Islam leader Louis Farrakhan: “Jews poisoned me….” “Jews hate me because I reveal their wickedness – Wake Up To The Truth

https://jonsnewplace.wordpress.com/2020/07/10/nation-of-islam-leader-louis-farrakhan-jews-poisoned-me-jews-hate-me-because-i-reveal-their-wickedness/

https://gellerreport.com/2020/07/farrakhan-jew-hatred.html/

By on July 08, 2020.

This is what the Democrat party promotes and exalts ginning up hatred and bigotry — under the banner of ‘fighting racism.’

By JNS and ILH Staff, Kuly 8, 2020:

On July 4, Nation of Islam leader Louis Farrakhan delivered a
three-hour speech that was streamed live on the Nation of Islam’s
YouTube channel. In the speech, Farrakhan said that Jews had poisoned
him with “radiated seed” to test whether he was truly a man of God, and
that his survival is proof that he is.

He said that prominent Jewish figures such as Alan Dershowitz and
former Trump administration Middle East negotiator Jason Greenblatt are
Satan, and emphasized that it is his job to expose Satan so that every
Muslim picks up a stone against him like they do during the pilgrimage
rituals in Mecca.

Farrakhan also said that the reason Jews hate him is because he
represents the end of their civilization and because he reveals their
wicked ways.

In addition, Farrakhan said that he is the one who exposed those who
“suck the blood” of the poor. Urging American mayors and governors not
to allow their police forces to train in Israel, Farrakhan claimed that
Israel is the reason that there are guns, drugs, and counterfeit money
in black neighborhoods. He added that Israel will suffer from divine
retribution and that it will not last long.

“I represent the uncovering of their wickedness, fulfilling the
judgment that God has come to bring down on America and the world,” said
Farrakhan.

Subscribe to Israel Hayom’s daily newsletter and never miss our top stories!

“So that’s why they hate me, Americans. Because they are wicked and
they know they cannot say that I am lying about them. They just say: ‘He
is a bigot. He is anti-Semitic,’” he added.

“Israel, let me tell you, your day is here now. You don’t have to
applaud. The God of justice has something for you, Israel. You are
troubling some waters and you won’t be there long if God gets after
you,” said Farrakhan.

Coronavirus Disease (COVID-19) Situation Reports|WHO

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Situation in numbers (by WHO Region)
Total (new cases in last 24 hours)
Globally 11 669 259 cases (168 957) 539 906 deaths (4 147) Africa 397 942 cases (15 379) 7 415 deaths (276) Americas 6 004 685 cases (89 134) 268 828 deaths (2 092) Eastern Mediterranean 1 204 698 cases (17 078) 28 664 deaths (562) Europe 2 827 789 cases (17 941) 201 255 deaths (604) South-East Asia 1 001 655 cases (27 266) 26 224 deaths (605) Western Pacific 231 749 cases (2 159) 7 507 deaths (8)

Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths, by WHO region. Data as of 10 AM CEST, 8 July 2020**

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case

Africa

South Africa 215 855 10 134 3 502 192 Community transmission 0 Nigeria 29 789 503 669 15 Community transmission 0 Ghana 21 968 1 883 129 7 Community transmission 0 Algeria 16 879 475 968 9 Community transmission 0 Cameroon 14 916 392 359 17 Community transmission 0 Côte d’Ivoire 10 966 0 75 0 Community transmission 1 Kenya 8 250 183 167 3 Community transmission 0 Democratic Republic of the Congo 7 659 228 182 1 Community transmission 0 Senegal 7 547 69 137 1 Community transmission 0 Ethiopia 6 774 108 120 1 Community transmission 0 Gabon 5 743 0 46 0 Community transmission 1 Guinea 5 636 26 34 0 Community transmission 0 Mauritania 4 948 69 133 3 Clusters of cases 0 Central African Republic 4 071 38 52 0 Community transmission 0 Madagascar 3 472 222 33 0 Clusters of cases 0 Mali 2 348 17 119 0 Community transmission 0 South Sudan 2 106 8 40 0 Clusters of cases 0 Zambia 1 895 263 42 12 Community transmission 0 Malawi 1 877 59 24 5 Clusters of cases 0 Guinea-Bissau 1 790 0 25 0 Community transmission 1 Congo 1 757 200 44 0 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Sierra Leone 1 572 25 63 1 Community transmission 0 Cabo Verde 1 499 36 18 1 Clusters of cases 0 Benin 1 285 86 23 2 Community transmission 0 Rwanda 1 172 59 3 0 Sporadic cases 0 Niger 1 094 1 68 0 Community transmission 0 Eswatini 1 056 45 14 1 Clusters of cases 0 Equatorial Guinea 1 043 0 12 0 Community transmission 45 Mozambique 1 040 28 8 0 Clusters of cases 0 Burkina Faso 1 003 3 53 0 Community transmission 0 Uganda 971 18 0 0 Sporadic cases 0 Liberia 917 26 41 2 Community transmission 0 Chad 873 1 74 0 Community transmission 0 Zimbabwe 787 53 9 0 Sporadic cases 0 Togo 689 9 15 0 Community transmission 0 Namibia 539 54 0 0 Sporadic cases 0 United Republic of Tanzania 509 0 21 0 Community transmission 61 Sao Tome and Principe 404 3 11 0 Clusters of cases 0 Angola 386 33 21 2 Clusters of cases 0 Mauritius 342 0 10 0 Clusters of cases 1 Botswana 314 0 1 0 Clusters of cases 1 Comoros 313 2 7 0 Community transmission 0 Eritrea 215 0 0 0 Sporadic cases 5 Burundi 191 0 1 0 Clusters of cases 4

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Lesotho 91 0 0 0 Sporadic cases 2 Seychelles 91 10 0 0 Clusters of cases 0 Gambia 61 0 3 0 Sporadic cases 1 Territoriesii
Mayotte 2 688 9 36 0 Clusters of cases 0 Réunion 551 1 3 1 Clusters of cases 0

Americas

United States of America 2 923 432 46 194 129 963 320 Community transmission 0

Brazil 1 623 284 20 229 65 487 620 Community transmission 0

Peru 305 703 2 985 10 772 183 Community transmission 0 Chile 301 019 2 462 6 434 50 Community transmission 0 Mexico 261 750 4 902 31 119 480 Community transmission 0 Colombia 120 281 3 171 4 210 146 Community transmission 0 Canada 105 935 399 8 693 9 Community transmission 0 Argentina 80 447 2 632 1 602 79 Community transmission 0 Ecuador 63 245 865 4 873 52 Community transmission 0 Bolivia (Plurinational State of) 40 509 1 212 1 476 42 Community transmission 0 Panama 39 334 1 185 770 23 Community transmission 0 Dominican Republic 38 430 302 821 17 Community transmission 0 Honduras 24 665 722 656 17 Community transmission 0 Guatemala 23 972 724 981 34 Community transmission 0 El Salvador 8 307 280 229 6 Community transmission 0 Venezuela (Bolivarian Republic of) 7 411 242 68 4 Community transmission 0 Haiti 6 371 38 113 0 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Costa Rica 5 241 245 23 4 Clusters of cases 0 Paraguay 2 502 46 20 0 Community transmission 0 Cuba 2 395 15 86 0 Clusters of cases 0 Nicaragua 2 182 0 83 0 Community transmission 6 Uruguay 960 4 29 1 Clusters of cases 0 Jamaica 737 5 10 0 Clusters of cases 0 Suriname 614 10 15 1 Clusters of cases 0 Guyana 278 5 16 1 Clusters of cases 0 Trinidad and Tobago 133 0 8 0 Sporadic cases 1 Bahamas 104 0 11 0 Clusters of cases 22 Barbados 98 0 7 0 Clusters of cases 1 Antigua and Barbuda 70 2 3 0 Clusters of cases 0 Belize 30 0 2 0 Sporadic cases 3 Saint Vincent and the Grenadines 29 0 0 0 Sporadic cases 20 Grenada 23 0 0 0 Clusters of cases 42 Saint Lucia 22 0 0 0 Sporadic cases 4 Dominica 18 0 0 0 Clusters of cases 25 Saint Kitts and Nevis 16 0 0 0 No cases 2 Territoriesii
Puerto Rico 8 714 129 157 2 Community transmission 0 French Guiana 5 178 124 21 1 Community transmission 0 Martinique 249 0 14 0 Clusters of cases 3 Cayman Islands 201 0 1 0 Clusters of cases 5 Guadeloupe 184 0 14 0 Clusters of cases 3

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Bermuda 146 0 9 0 Sporadic cases 17 United States Virgin Islands 116 4 6 0 Clusters of cases 0 Aruba 105 0 3 0 No cases 1 Sint Maarten 78 0 15 0 No cases 4 Turks and Caicos Islands 49 1 2 0 Clusters of cases 0 Saint Martin 44 0 3 0 Sporadic cases 3 Curaçao 25 0 1 0 No cases 7 Falkland Islands (Malvinas) 13 0 0 0 No cases 73 Montserrat 11 0 1 0 No cases 85 British Virgin Islands 8 0 1 0 No cases 53 Bonaire, Sint Eustatius and Saba 7 0 0 0 No cases 43 Saint Barthélemy 6 0 0 0 No cases 99 Anguilla 3 0 0 0 No cases 95 Saint Pierre and Miquelon 1 0 0 0 No cases 91

Eastern Mediterranean

Iran (Islamic Republic of) 245 688 2 637 11 931 200 Community transmission 0

Pakistan 237 489 2 980 4 922 83 Clusters of cases 0

Saudi Arabia 217 108 3 392 2 017 49 Clusters of cases 0 Qatar 100 945 600 134 1 Community transmission 0 Egypt 77 279 1 057 3 489 67 Clusters of cases 0 Iraq 64 701 2 426 2 685 118 Community transmission 0 United Arab Emirates 52 600 532 326 2 Community transmission 0 Kuwait 51 245 601 377 4 Clusters of cases 0 Oman 48 997 1 262 224 6 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Afghanistan 33 594 210 936 16 Clusters of cases 0 Bahrain 30 321 500 98 0 Clusters of cases 0 Morocco 14 607 228 240 3 Clusters of cases 0 Sudan 9 997 103 622 6 Community transmission 0 Djibouti 4 878 56 55 0 Clusters of cases 0 Somalia 3 015 9 92 0 Sporadic cases 0 Lebanon 1 907 22 36 0 Clusters of cases 0 Yemen 1 307 13 349 3 Community transmission 0 Tunisia 1 205 6 50 0 Sporadic cases 0 Libya 1 182 136 35 3 Clusters of cases 0 Jordan 1 169 2 10 0 Clusters of cases 0 Syrian Arab Republic 372 0 14 0 Community transmission 1 Territoriesii
occupied Palestinian territory
5 092 306 22 1
Clusters of cases
0

Europe

Russian Federation 700 792 6 562 10 667 173 Clusters of cases 0 The United Kingdom 286 353 581 44 391 155 Community transmission 0 Spain 252 130 341 28 392 4 Clusters of cases 0 Italy 241 956 137 34 899 30 Community transmission 0 Turkey 207 897 1 053 5 260 19 Community transmission 0 Germany 197 341 397 9 036 12 Clusters of cases 0 France 159 909 341 29 843 12 Community transmission 0 Sweden 73 344 283 5 447 14 Community transmission 0 Belarus 64 003 199 436 7 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Belgium 62 123 65 9 776 2 Community transmission 0 Kazakhstan 51 059 1 376 264 0 Clusters of cases 0 Netherlands 50 639 37 6 123 4 Community transmission 0 Ukraine 50 414 807 1 307 24 Community transmission 0 Portugal 44 416 287 1 629 9 Community transmission 0 Poland 36 412 257 1 528 7 Community transmission 0 Switzerland 32 284 54 1 685 0 Community transmission 0 Israel 31 137 1 082 336 5 Pending 0 Armenia 29 820 535 521 18 Community transmission 0 Romania 29 620 397 1 799 31 Community transmission 0 Ireland 25 538 7 1 743 2 Clusters of cases 0 Azerbaijan 21 374 537 265 7 Clusters of cases 0 Austria 18 415 89 706 0 Community transmission 0 Republic of Moldova 18 141 235 604 6 Community transmission 0 Serbia 16 719 299 330 13 Pending 0 Denmark 12 888 10 609 2 Community transmission 0 Czechia 12 685 119 351 1 Clusters of cases 0 Uzbekistan 10 838 379 41 3 Clusters of cases 0 Norway 8 936 6 251 0 Clusters of cases 0 Kyrgyzstan 8 486 345 112 13 Clusters of cases 0 Finland 7 262 5 329 0 Pending 0 North Macedonia 7 243 119 351 5 Clusters of cases 0 Tajikistan 6 315 53 53 0 Pending 0 Bulgaria 6 102 188 254 4 Clusters of cases 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Bosnia and Herzegovina 5 618 225 206 13 Community transmission 0 Luxembourg 4 603 61 110 0 Clusters of cases 0 Hungary 4 210 21 589 0 Community transmission 0 Greece 3 589 27 193 1 Clusters of cases 0 Croatia 3 272 52 113 0 Sporadic cases 0 Albania 3 106 68 83 2 Clusters of cases 0 Estonia 1 995 1 69 0 Clusters of cases 0 Iceland 1 873 7 10 0 Community transmission 0 Lithuania 1 844 3 79 0 Community transmission 0 Slovakia 1 767 2 28 0 Clusters of cases 0 Slovenia 1 739 23 111 0 Clusters of cases 0 Latvia 1 134 7 30 0 Sporadic cases 0 Cyprus 1 005 1 19 0 Clusters of cases 0 Georgia 963 5 15 0 Sporadic cases 0 Montenegro 907 66 17 3 Clusters of cases 0 Andorra 855 0 52 0 Community transmission 19 San Marino 713 0 42 0 Community transmission 18 Malta 673 1 9 0 Sporadic cases 0 Monaco 99 0 1 0 Sporadic cases 31 Liechtenstein 85 0 1 0 Pending 1 Holy See 12 0 0 0 Sporadic cases 62 Territoriesii Kosovo[1]
3 843 183 72 3 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Isle of Man 336 0 24 0 Pending 47 Jersey 325 5 31 0 Community transmission 0 Guernsey 252 0 13 0 Community transmission 66 Faroe Islands 188 1 0 0 Pending 0 Gibraltar 179 0 0 0 Clusters of cases 1 Greenland 13 0 0 0 Pending 40

South-East Asia

India 742 417 22 752 20 642 482 Clusters of cases 0

Bangladesh 168 645 3 027 2 151 55 Community transmission 0

Indonesia 66 226 1 268 3 309 68 Community transmission 0

Nepal 16 168 204 35 0 Sporadic cases 0 Thailand 3 197 2 58 0 Clusters of cases 0 Maldives 2 501 10 12 0 Clusters of cases 0 Sri Lanka 2 081 3 11 0 Clusters of cases 0 Myanmar 316 0 6 0 Clusters of cases 1 Bhutan 80 0 0 0 Sporadic cases 2 Timor-Leste 24 0 0 0 No cases 75

Western Pacific

China 85 366 21 4 648 0 Clusters of cases 0

Philippines 47 873 1 540 1 309 6 Community transmission 0

Singapore 45 140 157 26 0 Clusters of cases 0

Japan 20 174 193 980 2 Clusters of cases 0 Republic of Korea 13 244 63 285 0 Clusters of cases 0

Australia 8 755 169 106 0 Clusters of cases 0 Malaysia 8 674 6 121 0 Clusters of cases 0 New Zealand 1 187 1 22 0 Clusters of cases 0 Viet Nam 369 0 0 0 Clusters of cases 1 Mongolia 225 5 0 0 Sporadic cases 0 Brunei Darussalam 141 0 3 0 No cases 61 Cambodia 141 0 0 0 Sporadic cases 9 Fiji 21 2 0 0 Sporadic cases 0 Lao People’s Democratic Republic 19 0 0 0 Sporadic cases 86 Papua New Guinea 11 0 0 0 Sporadic cases 12 Territoriesii Guam
295 2 5 0 Clusters of cases 0 62 0 0 0 Sporadic cases 10
French Polynesia
Northern Mariana Islands (Commonwealth of the)
31 0 2 0 Pending 5
New Caledonia 21 0 0 0 Sporadic cases 28

Subtotal for all regions 11 668 518 168 957 539 893 4 147

Other* 741 0 13 0 Not applicable –

Grand total 11669259 168957 539906 4147

**See Annex 1 for data, table and figure notes.

Coronavirus Disease (COVID-19) Situation Reports|WHO

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Situation in numbers (by WHO Region)
Total (new cases in last 24 hours)
Globally 11 327 790 cases (202 545) 532 340 deaths (4 134) Africa 369 928 cases (13 262) 6 974 deaths (228) Americas 5 820 840 cases (122 886) 265 024 deaths (2 486) Eastern Mediterranean 1 170 720 cases (17 563) 27 566 deaths (492) Europe 2 791 160 cases (16 939) 200 238 deaths (357) South-East Asia 947 519 cases (28 928) 25 036 deaths (563) Western Pacific 226 882 cases (2 967) 7 489 deaths (8)

Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths, by WHO region. Data as of 10 AM CEST, 6 July 2020**

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case

Africa

South Africa 196 750 8 773 3 199 173 Community transmission 0

Nigeria 28 711 544 645 11 Community transmission 0

Ghana 20 085 697 122 5 Community transmission 0

Algeria 15 941 441 952 6 Community transmission 0

Cameroon 14 037 1 445 330 17 Community transmission 0 Côte d’Ivoire 10 244 0 70 0 Community transmission 1 Kenya 7 886 309 160 1 Community transmission 0 Democratic Republic of the Congo 7 410 32 181 0 Community transmission 0 Senegal 7 400 128 133 4 Community transmission 0 Ethiopia 6 386 0 116 0 Community transmission 1 Gabon 5 620 0 44 0 Community transmission 1 Guinea 5 610 40 34 0 Community transmission 0 Mauritania 4 879 174 130 1 Clusters of cases 0 Central African Republic 3 969 0 48 0 Community transmission 1 Madagascar 2 941 213 32 3 Clusters of cases 0 Mali 2 330 27 119 1 Community transmission 0 South Sudan 2 093 35 40 2 Clusters of cases 0 Guinea-Bissau 1 765 0 25 0 Community transmission 2 Malawi 1 742 129 19 2 Clusters of cases 0 Zambia 1 632 0 30 0 Community transmission 4 Congo 1 557 0 44 0 Community transmission 2

Sierra Leone 1 542 9 62 0 Community transmission 0 Cabo Verde 1 451 31 17 1 Clusters of cases 0 Benin 1 199 0 21 0 Community transmission 5 Rwanda 1 105 13 3 0 Sporadic cases 0 Niger 1 093 11 68 0 Community transmission 0 Equatorial Guinea 1 043 0 12 0 Community transmission 43 Burkina Faso 1 000 13 53 0 Community transmission 0 Eswatini 988 34 13 0 Clusters of cases 0 Mozambique 987 18 8 1 Clusters of cases 0 Uganda 939 12 0 0 Sporadic cases 0 Liberia 874 41 37 0 Community transmission 0 Chad 872 1 74 0 Community transmission 0 Zimbabwe 716 18 8 0 Sporadic cases 0 Togo 680 4 15 0 Community transmission 0 United Republic of Tanzania 509 0 21 0 Community transmission 59 Namibia 412 37 0 0 Sporadic cases 0 São Tomé and Príncipe 400 1 11 0 Clusters of cases 0 Angola 353 7 19 0 Clusters of cases 0 Mauritius 341 0 10 0 Clusters of cases 11 Comoros 311 2 7 0 Community transmission 0 Botswana 275 0 1 0 Clusters of cases 2 Eritrea 215 0 0 0 Sporadic cases 3 Burundi 191 0 1 0 Clusters of cases 2

Lesotho 91 12 0 0 Sporadic cases 0 Seychelles 81 0 0 0 Clusters of cases 6 Gambia 57 0 2 0 Sporadic cases 1 Territoriesii
Mayotte 2 668 0 36 0 Clusters of cases 1 Réunion 547 11 2 0 Clusters of cases 0

Americas

United States of America 2 833 552 57 186 129 408 182 Community transmission 0

Brazil 1 577 004 37 923 64 265 1 091 Community transmission 0

Peru 299 080 3 481 10 412 186 Community transmission 0

Chile 295 532 3 685 6 308 116 Community transmission 0

Mexico 252 165 6 914 30 366 523 Community transmission 0 Colombia 113 389 3 884 3 942 165 Community transmission 0 Canada 105 317 226 8 674 11 Community transmission 0 Argentina 75 376 2 590 1 490 37 Community transmission 0 Ecuador 61 958 423 4 781 12 Community transmission 0 Bolivia (Plurinational State of) 38 071 1 253 1 378 58 Community transmission 0 Dominican Republic 37 425 1 241 794 8 Community transmission 0 Panama 36 983 988 720 22 Community transmission 0 Honduras 22 921 805 629 24 Community transmission 0 Guatemala 22 501 1 208 920 40 Community transmission 0 El Salvador 7 777 270 217 7 Community transmission 0 Venezuela (Bolivarian Republic of) 6 750 213 62 3 Community transmission 0 Haiti 6 294 64 113 3 Community transmission 0

Costa Rica 4 621 310 18 0 Clusters of cases 0 Paraguay 2 427 42 20 0 Community transmission 0 Cuba 2 372 3 86 0 Clusters of cases 0 Nicaragua 2 182 0 83 0 Community transmission 4 Uruguay 955 3 28 0 Clusters of cases 0 Jamaica 728 7 10 0 Clusters of cases 0 Suriname 583 18 14 0 Clusters of cases 0 Guyana 272 16 14 0 Clusters of cases 0 Trinidad and Tobago 131 1 8 0 Sporadic cases 0 Bahamas 104 0 11 0 Clusters of cases 20 Barbados 97 0 7 0 Clusters of cases 20 Antigua and Barbuda 68 0 3 0 Clusters of cases 3 Belize 30 0 2 0 Sporadic cases 1 Saint Vincent and the Grenadines 29 0 0 0 Sporadic cases 18 Grenada 23 0 0 0 Clusters of cases 40 Saint Lucia 22 0 0 0 Sporadic cases 2 Dominica 18 0 0 0 Clusters of cases 23 Saint Kitts and Nevis 16 1 0 0 No cases 0 Territoriesii
Puerto Rico 7 916 129 155 0 Community transmission 0 French Guiana 4 913 0 16 0 Community transmission 1 Martinique 249 0 14 0 Clusters of cases 1 Cayman Islands 201 0 1 0 Clusters of cases 3 Guadeloupe 184 0 14 – 2 Clusters of cases 1

Bermuda 146 0 9 0 Sporadic cases 15 United States Virgin Islands 111 0 6 0 Clusters of cases 1 Aruba 104 0 3 0 No cases 2 Sint Maarten 78 0 15 0 No cases 2 Turks and Caicos Islands 47 2 2 0 Clusters of cases 0 Saint Martin 44 0 3 0 Sporadic cases 1 Curaçao 25 0 1 0 No cases 5 Falkland Islands (Malvinas) 13 0 0 0 No cases 71 Montserrat 11 0 1 0 No cases 83 British Virgin Islands 8 0 1 0 No cases 51 Bonaire, Sint Eustatius and Saba 7 0 0 0 No cases 41 Saint Barthélemy 6 0 0 0 No cases 97 Anguilla 3 0 0 0 No cases 93 Saint Pierre and Miquelon 1 0 0 0 No cases 89

Eastern Mediterranean

Iran (Islamic Republic of) 240 438 2 560 11 571 163 Community transmission 0

Pakistan 231 818 3 344 4 762 50 Clusters of cases 0

Saudi Arabia 209 509 3 580 1 916 58 Clusters of cases 0

Qatar 99 799 616 128 5 Community transmission 0

Egypt 75 253 1 218 3 343 63 Clusters of cases 0 Iraq 60 479 2 125 2 473 105 Community transmission 0 United Arab Emirates 51 540 683 323 2 Community transmission 0 Kuwait 49 941 638 368 3 Clusters of cases 0 Oman 46 178 1 072 213 10 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Afghanistan 33 064 113 887 23 Clusters of cases 0 Bahrain 29 367 510 97 1 Clusters of cases 0 Morocco 14 215 393 235 3 Clusters of cases 0 Sudan 9 767 0 608 0 Community transmission 1 Djibouti 4 792 56 55 0 Clusters of cases 0 Somalia 2 997 36 92 0 Sporadic cases 0 Lebanon 1 873 18 36 1 Clusters of cases 0 Yemen 1 269 17 339 1 Community transmission 0 Tunisia 1 188 7 50 0 Sporadic cases 0 Jordan 1 164 14 10 0 Clusters of cases 0 Libya 989 71 27 0 Clusters of cases 0 Syrian Arab Republic 358 20 13 3 Community transmission 0 Territoriesii
occupied Palestinian territory
4 722 472 20 1
Clusters of cases
0

Europe

Russian Federation 687 862 6 611 10 296 135 Clusters of cases 0

The United Kingdom 285 420 516 44 220 22 Community transmission 0

Spain 250 545 0 28 385 0 Clusters of cases 2

Italy 241 611 192 34 861 7 Community transmission 0

Turkey 205 758 1 148 5 225 19 Community transmission 0 Germany 196 554 219 9 016 4 Clusters of cases 0 France 158 734 0 29 808 0 Community transmission 2 Sweden 71 419 0 5 420 0 Community transmission 2 Belarus 63 554 284 423 5 Community transmission 0

Belgium 62 016 107 9 771 0 Community transmission 0 Netherlands 50 566 73 6 118 1 Community transmission 0 Ukraine 49 043 1 366 1 262 35 Community transmission 0 Kazakhstan 48 574 1 403 260 18 Clusters of cases 0 Portugal 43 897 328 1 614 9 Community transmission 0 Poland 35 950 231 1 517 5 Community transmission 0 Switzerland 32 184 70 1 685 0 Community transmission 0 Israel 29 236 803 330 4 Pending 0 Romania 28 973 391 1 750 19 Community transmission 0 Armenia 28 936 330 491 7 Community transmission 0 Ireland 25 527 18 1 741 0 Clusters of cases 0 Azerbaijan 20 324 523 250 9 Clusters of cases 0 Austria 18 269 73 706 1 Community transmission 0 Republic of Moldova 17 814 142 588 6 Community transmission 0 Serbia 16 131 302 311 5 Pending 0 Denmark 12 832 0 606 0 Community transmission 2 Czechia 12 515 75 348 – 3 Clusters of cases 0 Uzbekistan 10 143 314 35 4 Clusters of cases 0 Norway 8 895 0 251 0 Clusters of cases 3 Kyrgyzstan 7 691 597 92 14 Clusters of cases 0 Finland 7 253 5 329 0 Pending 0 North Macedonia 7 046 114 341 7 Clusters of cases 0 Tajikistan 6 213 54 53 1 Pending 0 Bulgaria 5 740 63 246 5 Clusters of cases 0

Bosnia and Herzegovina 5 393 144 193 3 Community transmission 0 Luxembourg 4 522 46 110 0 Clusters of cases 0 Hungary 4 183 0 589 0 Community transmission 1 Greece 3 519 8 192 0 Clusters of cases 0 Croatia 3 151 57 113 0 Sporadic cases 0 Albania 2 964 71 79 3 Clusters of cases 0 Estonia 1 993 0 69 0 Clusters of cases 1 Iceland 1 863 3 10 0 Community transmission 0 Lithuania 1 836 5 79 0 Community transmission 0 Slovakia 1 764 15 28 0 Clusters of cases 0 Slovenia 1 700 21 111 0 Clusters of cases 0 Latvia 1 124 1 30 0 Sporadic cases 0 Cyprus 1 003 1 19 0 Clusters of cases 0 Georgia 953 2 15 0 Sporadic cases 0 Andorra 855 0 52 0 Community transmission 17 Montenegro 781 61 14 1 Clusters of cases 0 San Marino 713 0 42 0 Community transmission 16 Malta 672 0 9 0 Sporadic cases 2 Monaco 99 0 1 0 Sporadic cases 29 Liechtenstein 84 0 1 0 Pending 2 Holy See 12 0 0 0 Sporadic cases 60 Territoriesii Kosovo[1]
3 465 152 65 11 Community transmission 0

Isle of Man 336 0 24 0 Pending 45 Jersey 320 0 31 0 Community transmission 1 Guernsey 252 0 13 0 Community transmission 64 Faroe Islands 187 0 0 0 Pending 73 Gibraltar 178 0 0 0 Clusters of cases 3 Greenland 13 0 0 0 Pending 38

South-East Asia

India 697 413 24 248 19 693 425 Clusters of cases 0

Bangladesh 162 417 2 738 2 052 55 Community transmission 0

Indonesia 63 749 1 607 3 171 82 Community transmission 0

Nepal 15 784 293 34 0 Sporadic cases 0 Thailand 3 195 5 58 0 Clusters of cases 0 Maldives 2 468 33 11 1 Clusters of cases 0 Sri Lanka 2 076 2 11 0 Clusters of cases 0 Myanmar 313 0 6 0 Clusters of cases 1 Bhutan 80 2 0 0 Sporadic cases 0 Timor-Leste 24 0 0 0 No cases 73

Western Pacific

China 85 320 14 4 648 0 Clusters of cases 0

Singapore 44 800 136 26 0 Clusters of cases 0

Philippines 44 254 2 424 1 297 7 Community transmission 0

Japan 19 775 253 977 0 Clusters of cases 0 Republic of Korea 13 137 46 284 1 Clusters of cases 0

Malaysia 8 663 5 121 0 Clusters of cases 0

Australia 8 449 87 104 0 Clusters of cases 0

New Zealand 1 184 1 22 0 Clusters of cases 0

Viet Nam 355 0 0 0 Clusters of cases 8

Mongolia 220 0 0 0 Sporadic cases 6 Brunei Darussalam 141 0 3 0 No cases 59 Cambodia 141 0 0 0 Sporadic cases 7 Fiji 19 1 0 0 Sporadic cases 0 Lao People’s Democratic Republic 19 0 0 0 Sporadic cases 84 Papua New Guinea 11 0 0 0 Sporadic cases

10 Territoriesii Guam
280 0 5 0 Clusters of cases 1 62 0 0 0 Sporadic cases 8
French Polynesia
Northern Mariana Islands (Commonwealth of the)
31 0 2 0 Pending 3
New Caledonia 21 0 0 0 Sporadic cases 26

Subtotal for all regions 11 327 049 202 545 532 327 4 134

Other* 741 0 13 0 Not applicable –

Grand total 11327790 202545 532340 4134

**See Annex 1 for data, table and figure notes.

China’s Serious Border Disputes With Most Neighbours – Unilateral Approach – India the Bulwark – Comprehensive Story – Air Power Asia

Comment by tonytran2015: (, posted 2017 April 01, , , ,
, posted 2017 Aug 24th., , France has NOT given to China Paracel and Spratly island, ).

https://airpowerasia.com/2020/07/06/chinas-serious-border-disputes-with-most-neighbours-unilateral-approach-india-the-bulwark-comprehensive-story/

The Galwan Valley Stand-off has once again brought the attention of the world to Chinese approach to border disputes. Disputes with some countries have been resolved through arm-twisting and there are some like Pakistan who have ceded huge areas of land to seek military and financial help and the end to a great extent ceded sovereignty. It is interesting to know the various disputes and the approach being taken.

Japan – The Disputed Islands in East China Sea

There is a territorial dispute over a group of uninhabited islands in the East China Sea called the Senkaku Islands in Japan and the Diaoyu in China…

China – Vietnam Border Dispute

The border between China consists of a terrestrial border, and a maritime border in Gulf of Tonkin and South China Sea (SCS)…

Nepal – China Boundary Issues

Nepal shares a 1,439km Himalayan border with China’s Tibet Autonomous Region, and was demarcated by surveyors of the two countries in 1963 after a two-year mission along the world’s highest mountains. The demarcation set Mt Everest on the boundary
between the two countries. China claims parts of Nepal dating back to the Sino-Nepalese War in 1788-1792, and says they were part of Tibet, therefore part of China. Nepalese media reports that several of its Himalayan villages are now in Chinese territory

China -North Korea – Paektu Mountain and Jiandao

There has been a historical dispute about the Paektu
Mountain. Manchu and Korean officials surveyed the area and negotiated a
border agreement in 1712. To mark the agreement, they built a monument
describing the boundary at a watershed, near the south of the crater
lake at the mountain peak. The interpretation of the inscription caused a
territorial dispute from the late 19th century to the early 20th
century, and is still disputed.

Sino-Soviet Border Issues

The Sino-Soviet border conflict was a seven-month
undeclared war in 1969. The most serious of these border clashes, occurred in March 1969 in the vicinity of Zhenbao Island on the Ussuri
River, near Manchuria. In 1933 in northwest China’s Xinjiang province, China’s nationalist Kuomintang recognized for the first time the ethnic category of the Uyghur people, following Soviet ethnic policy… These pre-modern states’ wars against Chinese dynasties were cast as struggles for national liberation by the Uyghur ethnic group. …

…the Chinese now indirectly demanded territorial concessions on the basis
that the 19th-century treaties transferring ownership of the sparsely populated Outer Manchuria, concluded by Qing dynasty of China and the Russian Empire, were “Unequal Treaties”, and amounted to annexation of
rightful Chinese territory…

South Korea and China

… both countries declared a 200 nautical mile (nm) exclusive economic zone
(EEZ), which resulted in significant overlap of the Chinese and South
Korean zones. Multiple rounds of meetings to conclude a delimitation
agreement, have not been successful…

China’s Claims on Bhutan

Unlike Tibet, Bhutan had no history of being under the suzerainty of China nor being under British
suzerainty during the British Raj.

…In July 1959, along with the occupation of Tibet, the Chinese PLA occupied several Bhutanese enclaves in western Tibet which were under Bhutanese administration for more than 300 years and had been given to Bhutan by a Ladakhi King Singye Namgya in the 17th century. These
included Darchen, Labrang Monastery, Gartok, and several smaller
monasteries and villages near Mount Kailas. A Chinese map published in 1961 showed China claiming territories in Bhutan, Nepal and the Kingdom of Sikkim (now a state of India)…

Taiwan — China Disputes and Relations

… the administration
of Taiwan was transferred from Japan at the end of World War II in 1945
and the subsequent split of China into the above two in 1949 as a result of civil war…

Laotian – Chinese relations

China claims large areas of Laos on historical precedent
(China’s Yuan Dynasty, 1271-1368)…. The low point in Sino-Laotian relations came in 1979, with reports of Chinese assistance and training of Hmong resistance forces under General Vang Pao in China’s Yunnan Province….This hostile relationship gradually softened…

China–Tajikistan Border Dispute – One sided Resolution

Chinese have claimed part of Tajikistan territory based on historical precedent (Qing Dynasty, 1644-1912). Their bilateral relations were established on January 4, 1992, shortly after the
dissolution of the Soviet Union…

Indonesia and Territorial disputes in the South China Sea

Parts of China’s unilaterally claimed nine-dash line overlap Indonesia’s exclusive Economic Zone (EEZ) near the Natuna islands

Mongolia – China Historic Issues

The Great Wall was constructed to ward off the northern nomads attacks,
from the Xiongnu during the Qin Dynasty, the Turks during the Tang Dynasty, and later, the Mongolians and Central Asians. In 1271, Mongols under Kublai Khan, grandson of Genghis Khan, established the Yuan Dynasty and conquered all of China in 1279. In 1368, the Chinese under the Ming Dynasty successfully expelled the
Mongols from China and in 1388, sacked the Northern Yuan’s capital at Karakorum…
Mongolia has always been suspicious that China wants to claim Mongolian territory based on some old historical documents that suit them, (a)nd concerned by fears of China’s over-population pouring into Mongolian territory...

Broad India China Dispute

Sovereignty over two relatively large and several smaller separated pieces of territoryhas been contested between China and India. The two major parts being the Aksai Chin in Indian union territory of Ladakh, currently administered by China as part of the Chinese autonomous region of Xinjiang. The other disputed territory lies south of the McMohan Line, formerly called the North East Frontier Agency, and is now called Arunachal Pradesh. The McMahon Line was part
of the 1914 Simla Convention between British India and Tibet, without participation of China. As of 2020, India continues to maintain that the McMahon Line as the legal border, while China has never accepted the border, stating
that Tibet was never independent. Around 1962, Chinese troops crossed
the McMahon line and, during a one-month war, pushed forward to establish a “Line of Actual Control”. A border conflict escalated into a second war in 1967, at the end of which India stated
it had established a new “Line of Actual Control”; no further military deaths occurred until 2020. In 1987 and in 2013 potential conflicts over the two differing Lines of Actual Control were successfully
de-escalated. A conflict involving a Bhutanese-controlled area on the
border between Bhutan and China was successfully de-escalated in 2017 following injuries to both Indian and Chinese troops. Multiple brawls broke out in 2020, escalating to dozens of deaths in June 2020…

China’s global cartographic aggression has no parallel. The periodicity with which China changes its territorial claims gives an indication that the Communist Party of China (CPC) randomly picks old maps that suit China’s hegemonic expansionist ambitions.

Practically in all disputes they have tried to expand territory. Be that with Russia, Pakistan, Tajiks, and in the South China Sea. In all these cases the countries chose not to stand up or fight the Chinese. The Vietnamese fought. Taiwan and Japan are taking firm stand. India has been taking a firm stand in last few years

As Bhutanese journalist Tenzing Lamsang writes “If we are to go by territorial claims then Greece, Rome, Mongolia, Spain and Britain should divide the world between the five of them. They would have maps, treaties, proof of tributes, evidence of rule and what not”.


Published by Anil Chopra

I am the founder of Air Power Asia and a retired Air Marshal from the Indian Air Force.

Remdesivir for Covid-19: $1.6 Billion for a “Modestly Beneficial” Drug? – Counter Information

https://counterinformation.wordpress.com/2020/07/03/remdesivir-for-covid-19-1-6-billion-for-a-modestly-beneficial-drug/

Global Research, July 03, 2020

The U.S. Department of Health and Human Services has recently “bought” all of Gilead Science’s Remdesivir for $1.6 billion. “500,000 doses at $3,200 per patient – to be available to American hospitals but not for other countries”[6]

That’s $1.6 billion tax dollars for a virtually untested drug showing only marginal efficacy in the hospital setting.

How could such a thing happen?

Introduction

If you believe an urgent call from the Yale School of Public Health that was recently published in the American Journal of Epidemiology— the top epidemiology journal in America — hydroxychloroquine (HCQ) + azithromycin is the quickest and most effective way to halt the Covid-19 pandemic.[1]

According to this Yale statement, hydroxychloroquine – a cheap, natural anti-malarial tree-bark known as quinine for 400 years – is highly effective during Phase 1 of Covid-19, while the virus is loading into the body.

As the first line of defense, it should be immediately, freely, and widely available to symptomatic high-risk patients – through doctors’ offices, outpatient clinics, and hospitals across the land.

Indeed, under the directorship of Dr. Anthony Fauci, a National Institute of Allergy and Infectious Diseases (NIAID) a clinical trial had been launched on May 14 to look into it.[2]

The HCQ + azithromycin protocol is being used successfully by France’s top, award-winning microbiologist, Dr. Didier Raoult. He is director of the Infectious and Tropical Emergent Diseases Research Unit in Marseille (Institut Hospitalo-Universitaire) (IHU), with 200 staff. Raoult, now almost a celebrity in France, has recently published his protocol and results, showing an overall 1.1% case fatality rate.[3]

The same protocol has also been highly successful in China, India, Senegal, and Brazil.[4]

So why suddenly is the U.S. government and the media ignoring recommendations from these top specialists,[5] and waiting, instead, until people get very sick and hospitalized to treat them with the relatively untested drug, Remdesivir, which is administered intravenously?

Why has the U.S. Department of Health and Human Services just bought up all the Remdesivir it could order – 500,000 doses at $3,200 per patient – to be available to American hospitals but not for other countries?[6]

To put Remdesivir’s cost in perspective, the CDC reports that the flu vaccine costs from $12-$18 a dose.[7]

The government, in order to justify its mind-boggling price, would need to show exceptional efficacy in saving lives. Efficacy, that is, once the disease has been allowed, through failure to use the HCQ + azithromycinearly preventive approach, to advance to Phase 2 (the dangerous inflammatory period) and Phase 3 (ICU ventilator intubation, often leading to death).[8]

What do studies say about the efficacy of remdesivir?

There are three main studies that have examined remdesivir as a treatment for Covid-19:

  1. The first, a study of seriously ill patients, was originally reported in the New England Journal of Medicine on April 10, 2020. Treated with “compassionate-use” remdesivir, clinical improvement was observed in 36 of 53 patients (68%).

The article was co-authored by 56 people, some of whom were on the staff of remdesivir’s producer, Gilead Sciences.[9] The study was funded by Gilead, and writing assistance was provided by David McNeel, also of Gilead.[10]

The following day, April 11, the Science Media Centre published expert reactions to the compassionate study from five British university professors. These assessments were not encouraging: “the research doesn’t prove anything at this point;” “the data is almost uninterpretable;” the research should be treated “with extreme caution.”[11]

  1. A Wuhan, China randomized, double-blind, placebo-controlled trial of 237 patients was accidentally leaked by the World Health Organization and published in The Lancet. It showed no statistically significant clinical benefits from remdesivir:

“The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from dying, according to results from a long-awaited clinical trial conducted in China.” [12]

This Lancet study also found that some 14% of patients in the treatment group died after 28 days, compared to 13% in the group that did not receive the treatment.

And it further reported that “remdesivir was stopped early because of adverse events in 18 (12%) patients versus four (5%) patients who stopped placebo early.”[13]

  1. The preliminary results of a NIAID remdesivir trial of 1063 patients showed a “modest” benefit in a controlled clinical trial:

“The infected people who received remdesivir, an experimental drug made by Gilead Sciences that cripples an enzyme several viruses use to copy their RNA, recovered in an average of 11 days versus 15 in patients who received a placebo. ‘Although a 31% improvement doesn’t seem like a knockout, 100% [success], it is a very important proof of concept,’ said Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID).”[14]

Health Policy Watch reported that “the death rate was 8% in the group that received remdesivir compared to 11.6% in the control group, although this result was not statistically significant.” Dr. Fauci told reporters that “what [this trial] has proven is that a drug can block the virus.”[15]

The excerpt below from a June 24 article in the British Medical Journal assesses the problems in the foregoing studies. (One of the four co-authors, Fiona Godlee, is the editor-in-chief of the BMJ):

“A serious imbalance in covid-19 research strongly favours the study of drug treatments over non-drug interventions, with many studies too small or too weak to produce reliable results. Equally concerning is the release of partial or preliminary findings before peer review—often through commercial press releases—that is distorting public perceptions, ongoing evaluations efforts, and political responses to the pandemic.

Remdesivir is a key example. The antiviral drug, made by US company Gilead, was unapproved at the start of the pandemic, but in early April the New England Journal of Medicine published a small descriptive study of a compassionate use scheme for patients with covid-19. Gilead funded the study, a third of the authors were Gilead employees, and Gilead’s press release reported “clinical improvement in 68% of patients in this limited dataset.” Despite being a non-randomised, uncontrolled, company funded study of just 53 patients, media headlines described “hopeful” signs and reported “two thirds” of patients showing improvement.[16]

Two weeks later, the Lancet published a randomised placebo controlled trial of remdesivir from China, finding no statistically significant clinical benefit in the primary outcome of time to clinical improvement. Twelve per cent of participants taking remdesivir stopped treatment early because of adverse events, compared with 5% taking placebo. The trial was stopped before meeting recruitment targets.”[17]

To summarize, the only study demonstrating even marginal efficacy for remdesivir shows it to reduce hospital recovery times 31%, from 15 days to 11 days.

What is the justification for spending $3,200 tax dollars per Covid-19 patient to save four days in hospital, unless it is to shorten hospital stays, thereby saving the average U.S. bed cost of approximately $2000 per day, while delaying hospital saturation that could leave some people untreated to die?

Leaving people untreated to die could cause civil unrest, which may be the covert political reason for spending the $1.6 trillion.

None of the studies mention side effects of the drug. In the China study, kidney injury led to discontinuation for one patient, and in its use for ebola, liver risks were identified.[18]

How much does it cost to produce remdesivir?

The Institute for Clinical and Economic Review (ICER) is a non-profit organization seeking to improve healthcare value through clinical and cost-effective analyses.[19]

In a May 1, 2020 study, the ICER calculated that the cost of producing the remdesivir “final finished product,” including the pharmaceutical ingredients, formulation, packaging, and a small profit margin, was $9.32 US for a 10-day course of treatment. They rounded this up to $10.[20]

Dr. Fauci’s NIAID Clinical Trial Evaluating Hydroxychloroquine and Azithromycin Closes Early

On June 20, 2020, nine days before the Department of Health and Human Services announced its $1.6 trillion purchase of remdesivir on June 29, its NIAID branch closed a clinical trial that had been launched May 14 to investigate whether the inexpensive combination, hydroxychloroquine plus azithromycin, might be an effective treatment when given early in the course of the disease.[21]

The Department of Health and Human Services knew that hydroxychloroquine (aka chloroquine) was effective against coronavirus because chloroquine was tested against the SARS-1 virus during the outbreak in 2002. This work was written up in 2005, under the auspices of the U.S. Centers for Disease Control in Atlanta, which reports to the Department of Human Health and Services.[22]

Truth, as the saying goes, is stranger than fiction.

Who was responsible for this debacle?

Dr. Fauci has served in the National Institutes of Health under six presidents.

Were these bizarre decisions carried out under his authority? Or were they forced upon him from higher up? Or has he become a victim of regulatory capture[23] by the drug industry?

Whatever the answer, this unprecedented fleecing of the American public should have been shouted from the rooftops, had there been a functioning US media.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Notes

[1] Harvey A. Risch, “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis,” Amer. J. Epid, 27 May 2020 (https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586). Risch is Professor at the Yale Schools of both Medicine and Public Health.

[2] National Institute of Allergy and Infectious Diseases, “NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19,” 14 May 2020 (https://www.niaid.nih.gov/news-events/nih-begins-clinical-trial-hydroxychloroquine-and-azithromycin-treat-covid-19).

[3] Jean-Christophe Lagier, et al, “Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis,” Travel Medicine and Infectious Disease, 25 June 2020 (https://www.sciencedirect.com/science/article/pii/S1477893920302817). Rault has 2,300 indexed medical journals in print.

[4] The group “COVEXIT.com – News About Hydroxychloroquine & Other COVID-19 Treatments,” was founded March 29, 2020 by Jean-Pierre Kiekens. It keeps daily track of successful Covid treatments worldwide (https://www.facebook.com/groups/covexit)

[5] Elizabeth Woodworth, “The Media Sabotage of Hydroxychloroquine Use for COVID-19: Doctors Worldwide Protest the Disaster,” Global Research, 30 June 2020 (https://www.globalresearch.ca/media-sabotage-hydroxychloroquine-covid-19-doctors-worldwide-protest-disaster/5717382).

[6] US Department of Health and Human Services, “Trump Administration Secures New Supplies of Remdesivir for the United States,” June 29, 2010 (https://www.hhs.gov/about/news/2020/06/29/trump-administration-secures-new-supplies-remdesivir-united-states.html).

[7] Centers for Disease Control and Prevention, Vaccines for Children Program, “CDC Vaccine Price List,” updated 1 July 2020 (https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html#adflu).

[8] Dr. Raoult identified the three stages of Covid-19 while treating 3,737 patients with HCQ+azithromycin at his own clinic: “At the first viral stage, one must give medicines against the virus, in the second inflammatory phase, one needs to give medications against that [inflammatory] reaction, and then in the third phase, it’s work to be done in intensive care units.” Summarized from Didier Raoult, at: “The Marx Brothers are Doing Science: the Example of RECOVERY,” 9 June 2020 (http://covexit.com/professor-raoult-compares-the-oxford-recovery-trial-academics-to-the-marx-brothers/).

[9] Jonathan Grein, and 55 other authors, “Compassionate Use of Remdesivir for Patients with Severe Covid-19,” New England Journal of Medicine, 11 June 2020 (https://www.nejm.org/doi/full/10.1056/NEJMoa2007016), “Editor’s Note: This article was published on April 10, 2020, at NEJM.org.”

[10] Jason D. Goldman, et al., “Remdesivir for 5 or 10 days in Patients with Severe Covid,” New England Journal of Medicine, no date in header (https://www.nejm.org/doi/pdf/10.1056/NEJMoa2015301?articleTools=true). Sidebar:“This article was published on May 27, 2020, at NEJM.org.”

[11] Prof. Duncan Richards et al., “Expert reaction to a study about compassionate use of remdesivir for patients with severe COVID-19,” Science Media Centre, 11 April 2020 (https://www.sciencemediacentre.org/expert-reaction-to-a-study-about-compassionate-use-of-remdesivir-for-patients-with-severe-covid-19/).

[12] Ed Silverman, et al, “New data on Gilead’s remdesivir, released by accident, show no benefit for coronavirus patients. Company still sees reason for hope,” StatNews, 23 April 2020 (https://www.statnews.com/2020/04/23/data-on-gileads-remdesivir-released-by-accident-show-no-benefit-for-coronavirus-patients/).

[13] Yeming Wang, et al., “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial,” The Lancet, 16 May 2020 (original online publication 29 April 2020) (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext).

[14] Jon Cohen, “Large trial yields strongest evidence yet that antiviral drug can help COVID-19 patients,” Science, 29 April 2020 (https://www.sciencemag.org/news/2020/04/large-trial-yields-strongest-evidence-yet-antiviral-drug-can-help-covid-19-patients).

[15] Grace Ren, “Conflicting Remdesivir Trial Results Released; Experts Urge More Research,” Health Policy Watch, 29 April 2020 (https://healthpolicy-watch.news/first-remdesivir-rct-shows-no-significant-clinical-benefit-for-severe-covid-19-patients-but-experts-urge-for-more-research/).

[16] Christopher Rowland, “Gilead’s experimental drug remdesivir shows ‘hopeful’ signs in small group of coronavirus patients,” Washington Post, 10 April 2020 (https://www.washingtonpost.com/business/2020/04/10/gileads-experimental-drug-remdesivir-shows-hopeful-signs-small-group-coronavirus-patients/).

[17] Ray Moynihan et al.,“Commercial influence and covid-19,” BMJ2020;369:m2456 (Published 24 June 2020) (https://www.bmj.com/content/369/bmj.m2456).

[18] Crystal Phend, “Remdesivir Safety Forecast: Watch the Liver, Kidneys,” Medpage Today, 19 May 2020 (https://www.medpagetoday.com/infectiousdisease/covid19/86582).

[19] https://en.wikipedia.org/wiki/Institute_for_Clinical_and_Economic_Review

[20] Melanie D. Whittington and Jonathan B. Campbell, “Alternative Pricing Models for Remdesivir and Other Potential Treatments for COVID-19,” Institute for Clinical and Economic Review, 1 May 2020 (https://icer-review.org/wp-content/uploads/2020/05/ICER-COVID_Initial_Abstract_05012020-3.pdf).

[21] National Institute of Allergy and Infectious Diseases, “BULLETIN—NIH Clinical Trial Evaluating Hydroxychloroquine and Azithromycin for COVID-19 Closes Early,” 20 June 2020 (https://www.niaid.nih.gov/news-events/bulletin-nih-clinical-trial-evaluating-hydroxychloroquine-and-azithromycin-covid-19).

[22] Martin J. Vincent et al., “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread,” Journal of Virology, 22 August 2005 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/).

[23] “Regulatory capture is a theory that regulatory agencies may be dominated by the interests they regulate and not by the public interest.” In: Will Kenton, “Regulatory Capture,” Investopedia, 23 October 2019 (https://www.investopedia.com/terms/r/regulatory-capture.asp).

Coronavirus Disease (COVID-19) Situation Reports|WHO

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Situation in numbers (by WHO Region)
Total (new cases in last 24 hours)
Globally 10 357 662 cases (163 939) 508 055 deaths (4 188) Africa 306 794 cases (9 504) 6 192 deaths (182) Americas 5 218 590 cases (81 885) 249 318 deaths (2 189) Eastern Mediterranean 1 077 426 cases (19 371) 24 970 deaths (547) Europe 2 728 059 cases (27 624) 197 874 deaths (615) South-East Asia 808 906 cases (23 975) 22 235 deaths (642) Western Pacific 217 146 cases (1 580) 7 453 deaths (13)

Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths, by WHO region. Data as of 10 AM CEST, 1 July 2020**

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case

Africa

South Africa 151 209 6 945 2 657 128 Community transmission 0

Nigeria 25 694 561 590 17 Community transmission 0

Ghana 17 741 390 112 0 Community transmission 0

Algeria 13 907 336 912 7 Community transmission 0

Cameroon 12 592 0 313 0 Community transmission 5 Côte d’Ivoire 9 214 113 66 0 Community transmission 0 Democratic Republic of the Congo 7 038 100 169 3 Community transmission 0 Senegal 6 793 95 112 4 Community transmission 0 Kenya 6 366 176 148 4 Community transmission 0 Ethiopia 5 846 0 103 0 Community transmission 1 Gabon 5 394 0 42 0 Community transmission 1 Guinea 5 391 40 33 2 Community transmission 0 Mauritania 4 237 88 128 2 Clusters of cases 0 Central African Republic 3 745 132 47 0 Community transmission 0 Madagascar 2 214 76 20 0 Clusters of cases 0 Mali 2 181 8 116 1 Community transmission 0 South Sudan 2 007 1 38 1 Clusters of cases 0 Guinea-Bissau 1 654 0 24 0 Community transmission 1 Zambia 1 594 26 24 2 Community transmission 0 Sierra Leone 1 462 12 60 0 Community transmission 0 Congo 1 329 84 41 1 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Malawi 1 265 41 16 2 Clusters of cases 0 Cabo Verde 1 227 62 15 3 Clusters of cases 0 Benin 1 199 12 21 2 Community transmission 0 Niger 1 075 0 67 0 Community transmission 1 Equatorial Guinea 1 043 0 12 0 Community transmission 38 Rwanda 1 025 24 2 0 Sporadic cases 0 Burkina Faso 962 3 53 0 Community transmission 0 Mozambique 889 6 6 1 Clusters of cases 0 Uganda 889 19 0 0 Sporadic cases 0 Chad 866 0 74 0 Community transmission 2 Eswatini 812 17 11 0 Clusters of cases 0 Liberia 780 10 36 0 Community transmission 0 Togo 643 1 14 0 Community transmission 0 Zimbabwe 591 17 7 0 Sporadic cases 0 United Republic of Tanzania 509 0 21 0 Community transmission 54 São Tomé and Principe 394 1 11 0 Clusters of cases 0 Mauritius 341 0 10 0 Clusters of cases 6 Comoros 303 10 7 0 Community transmission 0 Angola 284 8 13 2 Clusters of cases 0 Botswana 227 52 1 0 Clusters of cases 0 Eritrea 203 12 0 0 Sporadic cases 0 Namibia 203 20 0 0 Sporadic cases 0 Burundi 170 0 1 0 Clusters of cases 2

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Seychelles 81 0 0 0 Clusters of cases 1 Gambia 49 2 2 0 Sporadic cases 0 Lesotho 27 0 0 0 Sporadic cases 2 Territoriesii
Mayotte 2 603 0 35 0 Clusters of cases 1 Réunion 526 4 2 0 Clusters of cases 0

Americas

United States of America 2573393 35757 126573 370 Community transmission 0

Brazil 1 368 195 24 052 58 314 692 Community transmission 0

Peru 282 365 2 946 9 504 187 Community transmission 0

Chile 279 393 3 394 5 688 113 Community transmission 0

Mexico 220 657 3 805 27 121 473 Community transmission 0 Canada 103 918 668 8 566 44 Community transmission 0 Colombia 95 043 3 274 3 223 117 Community transmission 0 Argentina 62 268 2 335 1 283 38 Community transmission 0 Ecuador 56 342 677 4 527 25 Community transmission 0 Panama 32 785 1 099 620 16 Community transmission 0 Dominican Republic 32 568 752 747 14 Community transmission 0 Bolivia (Plurinational State of) 32 125 601 1 071 57 Community transmission 0 Honduras 18 818 736 485 6 Community transmission 0 Guatemala 17 409 479 746 19 Community transmission 0 El Salvador 6 438 265 174 10 Community transmission 0 Haiti 5 933 86 105 1 Community transmission 0 Venezuela (Bolivarian Republic of) 5 530 233 48 4 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Costa Rica 3 269 139 15 0 Clusters of cases 0 Cuba 2 341 1 86 0 Clusters of cases 0 Paraguay 2 221 94 17 2 Community transmission 0 Nicaragua 2 014 0 74 0 Community transmission 13 Uruguay 932 3 27 0 Clusters of cases 0 Jamaica 698 2 10 0 Clusters of cases 0 Suriname 515 23 13 0 Clusters of cases 0 Guyana 235 5 12 0 Clusters of cases 0 Trinidad and Tobago 130 4 8 0 Sporadic cases 0 Bahamas 104 0 11 0 Clusters of cases 15 Barbados 97 0 7 0 Clusters of cases 15 Antigua and Barbuda 66 1 3 0 Clusters of cases 0 Saint Vincent and the Grenadines 29 0 0 0 Sporadic cases 13 Belize 24 0 2 0 Sporadic cases 3 Grenada 23 0 0 0 Clusters of cases 35 Saint Lucia 19 0 0 0 Sporadic cases 25 Dominica 18 0 0 0 Clusters of cases 18 Saint Kitts and Nevis 15 0 0 0 No cases 71 Territoriesii
Puerto Rico 7 465 215 153 0 Community transmission 0 French Guiana 4 004 230 15 0 Community transmission 0 Martinique 242 0 14 0 Clusters of cases 3 Cayman Islands 199 3 1 0 Clusters of cases 0 Guadeloupe 182 0 14 0 Clusters of cases 4

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Bermuda 146 0 9 0 Sporadic cases 10 Aruba 103 2 3 0 No cases 0 United States Virgin Islands 84 3 6 0 Clusters of cases 0 Sint Maarten 77 0 15 0 No cases 25 Saint Martin 43 0 3 0 Sporadic cases 1 Turks and Caicos Islands 41 0 2 1 Clusters of cases 1 Curaçao 25 1 1 0 No cases 0 Falkland Islands (Malvinas) 13 0 0 0 No cases 66 Montserrat 11 0 1 0 No cases 78 British Virgin Islands 8 0 1 0 No cases 46 Bonaire, Sint Eustatius and Saba 7 0 0 0 No cases 36 Saint Barthélemy 6 0 0 0 No cases 92 Anguilla 3 0 0 0 No cases 88 Saint Pierre and Miquelon 1 0 0 0 No cases 84

Eastern Mediterranean

Iran (Islamic Republic of) 227 662 2 457 10 817 147 Community transmission 0

Pakistan 213 470 4 133 4 395 91 Clusters of cases 0

Saudi Arabia 190 823 4 387 1 649 50 Clusters of cases 0

Qatar 96 088 982 113 0 Community transmission 0

Egypt 68 311 1 557 2 953 81 Clusters of cases 0 Iraq 49 109 1 958 1 943 104 Community transmission 0 United Arab Emirates 48 667 421 315 1 Community transmission 0 Kuwait 46 195 671 354 4 Clusters of cases 0 Oman 40 070 1 010 176 7 Community transmission 0

Afghanistan 31 762 524 774 41 Clusters of cases 0 Bahrain 26 758 519 87 3 Clusters of cases 0 Morocco 12 533 243 228 3 Clusters of cases 0 Sudan 9 258 0 572 0 Community transmission 4 Djibouti 4 682 26 54 1 Clusters of cases 0 Somalia 2 924 20 90 0 Sporadic cases 0 Lebanon 1 778 33 34 0 Clusters of cases 0 Tunisia 1 174 2 50 0 Sporadic cases 0 Yemen 1 162 30 313 8 Community transmission 0 Jordan 1 132 4 9 0 Clusters of cases 0 Libya 824 62 24 3 Clusters of cases 0 Syrian Arab Republic 279 10 9 0 Community transmission 0

Territoriesii occupied Palestinian territory
2 765 322 11 3 Clusters of cases 0

Europe

Russian Federation 654 405 6 556 9 536 216 Clusters of cases 0

The United Kingdom 312 658 689 43 730 155 Community transmission 0

Spain 249 271 301 28 355 9 Community transmission 0

Italy 240 578 142 34 767 23 Community transmission 0

Turkey 199 906 1 293 5 131 16 Community transmission 0

Germany 194 725 466 8 985 12 Clusters of cases 0

France 157 194 264 29 760 30 Community transmission 0

Sweden 68 451 784 5 333 23 Community transmission 0

Belarus 62 118 328 392 5 Community transmission 0

Belgium 61 509 82 9 754 2 Community transmission 0 Netherlands 50 273 50 6 113 6 Community transmission 0 Ukraine 44 998 664 1 173 14 Community transmission 0 Portugal 42 141 229 1 576 8 Community transmission 0 Kazakhstan 41 065 10 897 188 0 Clusters of cases 0 Poland 34 393 239 1 463 19 Community transmission 0 Switzerland 31 631 62 1 683 2 Community transmission 0 Romania 26 970 388 1 651 17 Community transmission 0 Armenia 26 065 523 453 10 Community transmission 0 Ireland 25 473 11 1 736 1 Clusters of cases 0 Israel 24 567 737 319 0 Pending 0 Austria 17 777 111 705 2 Community transmission 0 Azerbaijan 17 524 556 213 7 Clusters of cases 0 Republic of Moldova 16 613 256 547 6 Community transmission 0 Serbia 14 564 276 277 3 Pending 0 Denmark 12 768 17 605 0 Community transmission 0 Czechia 11 954 149 349 1 Clusters of cases 0 Norway 8 865 10 250 1 Clusters of cases 0 Uzbekistan 8 627 329 26 2 Clusters of cases 0 Finland 7 214 5 328 0 Pending 0 North Macedonia 6 350 126 302 4 Clusters of cases 0 Tajikistan 5 954 54 52 0 Pending 0 Kyrgyzstan 5 735 439 62 5 Clusters of cases 0 Bulgaria 4 989 158 230 7 Clusters of cases 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Bosnia and Herzegovina 4 453 110 185 2 Community transmission 0 Luxembourg 4 299 43 110 0 Clusters of cases 0 Hungary 4 155 10 585 0 Community transmission 0 Greece 3 409 19 192 1 Clusters of cases 0 Croatia 2 777 52 107 0 Sporadic cases 0 Albania 2 580 45 65 3 Clusters of cases 0 Estonia 1 989 2 69 0 Clusters of cases 0 Iceland 1 842 2 10 0 Community transmission 0 Lithuania 1 817 1 78 0 Community transmission 0 Slovakia 1 667 2 28 0 Clusters of cases 0 Slovenia 1 600 15 111 0 Clusters of cases 0 Latvia 1 118 1 30 0 Sporadic cases 0 Cyprus 998 2 19 0 Clusters of cases 0 Georgia 931 3 15 0 Sporadic cases 0 Andorra 855 0 52 0 Community transmission 12 San Marino 713 0 42 0 Community transmission 11 Malta 670 0 9 0 Sporadic cases 4 Montenegro 548 47 12 1 Clusters of cases 0 Monaco 99 0 1 0 Sporadic cases 24 Liechtenstein 83 0 1 0 Pending 66 Holy See 12 0 0 0 Sporadic cases 55 Territoriesii Kosovo[1]
2 835 79 41 2 Community transmission 0

Reporting Country/ Territory/Area Total confirmed cases
Total confirmed new cases
Total deaths Total new deaths Transmission classificationi
Days since last reported case
Isle of Man 336 0 24 0 Pending 40 Jersey 319 0 31 0 Community transmission 5 Guernsey 252 0 13 0 Community transmission 59 Faroe Islands 187 0 0 0 Pending 68 Gibraltar 177 0 0 0 Clusters of cases 2 Greenland 13 0 0 0 Pending 33

South-East Asia

India 585 493 18 653 17 400 507 Clusters of cases 0

Bangladesh 145 483 3 682 1 847 64 Community transmission 0

Indonesia 56 385 1 293 2 876 71 Community transmission 0

Nepal 13 564 316 29 0 Sporadic cases 0 Thailand 3 173 2 58 0 Clusters of cases 0 Maldives 2 361 24 8 0 Clusters of cases 0 Sri Lanka 2 047 5 11 0 Clusters of cases 0 Myanmar 299 0 6 0 Clusters of cases 2 Bhutan 77 0 0 0 Sporadic cases 1 Timor-Leste 24 0 0 0 No cases 68

Western Pacific

China 85 232 5 4 648 0 Clusters of cases 0

Singapore 43 907 246 26 0 Clusters of cases 0

Philippines 37 514 1 076 1 266 11 Community transmission 0 Japan 18 723 130 974 2 Clusters of cases 0 Republic of Korea 12 850 50 282 0 Clusters of cases 0

Malaysia 8 639 2 121 0 Clusters of cases 0

Australia 7834 67 104 0 Clusters of cases 0

New Zealand 1 178 0 22 0 Clusters of cases 2

Viet Nam 355 0 0 0 Clusters of cases 3 Mongolia 220 0 0 0 Sporadic cases 1

Brunei Darussalam 141 0 3 0 No cases 54 Cambodia 141 0 0 0 Sporadic cases 2 Lao People’s Democratic Republic 19 0 0 0 Sporadic cases 79 Fiji 18 0 0 0 Sporadic cases 71 Papua New Guinea 11 0 0 0 Sporadic cases 5 Territoriesii
Guam 251 4 5 0 Clusters of cases 0 French Polynesia 62 0 0 0 Sporadic cases 3
Northern Mariana Islands (Commonwealth of the)
30 0 2 0 Pending 21
New Caledonia 21 0 0 0 Sporadic cases 21

Subtotal for all regions 10 356 921 163 939 508 042 4 188

Other* 741 0 13 0 Not applicable –

Grand total 10357662 163939 508055 4188

**See Annex 1 for data, table and figure notes.

Vietnam Airlines flight landing aborted after air traffic flags gear failure -OLD NEWS| 7NEWS.com.au

https://7news.com.au/travel/vietnam-airlines-flight-landing-aborted-after-air-traffic-flags-gear-failure-c-462432

Caroline Schelle

Friday, 20 September 2019 7:43 am

A Vietnam Airlines flight came within a minute of touching down on the tarmac at Melbourne Airport when air traffic controllers realised the plane’s landing gear
wasn’t deployed.

The Boeing 787 Dreamliner was flying into Melbourne from Ho Chi Minh City when the issue was spotted at 8.04am on Thursday, according to the air safety bureau.

“During approach to land, Melbourne Air Traffic Control advised the crew that the aircraft’s landing gear was observed not to be extended,” the Australian Transport Safety Bureau said in a statement.

Related news from other sources:

“Theo tôi, không phải do phi công quên thả càng vì tất cả các dòng máy bay thương mại hiện đại (bao gồm 787) đều có hệ thống báo động bằng giọng nói, sẽ nhắc phi công nếu càng chưa được thả
khi vào hạ cánh”, phi công (xin giấu tên) phân tích tình huống.
“Trong trường hợp này, tôi nghĩ phi công đã có một chút lúng túng trong quá trình thực hiện tiếp cận, họ phải tập trung ổn định quỹ đạo
bay dẫn đến thả càng muộn và phải thực hiện bay lại”, phi công này nhận định.

Về nguyên nhân trực tiếp của sự cố, phi công dày dạn kinh nghiệm này cho rằng có thể là sự mệt mỏi sau 8 giờ bay từ TPHCM dẫn đến việc phi
công bị suy giảm sự tỉnh táo và thao tác chậm. “Vấn đề này là rất quan trọng trong khai thác bay, đặc biệt là các chuyến bay dài cắt qua nhiều
múi giờ”, anh nhấn mạnh.

https://zingnews.vn/phi-cong-lai-787-cua-vietnam-airlines-da-lung-tung-post992240.html